Crohn’s Disease Treatment? Why Am I Unable to Recover from Crohn’s Disease?
Estimated reading time: 6 minutes
Table of Contents
Crohn’s Disease is a long-term inflammatory condition of the digestive tract, also known as an Inflammatory Bowel Disease (IBD). It results in painful inflammation, leading to symptoms such as abdominal pain, diarrhea, weight loss, and fatigue. Crohn’s can affect any part of the digestive system, from the mouth to the anus, but it most commonly impacts the small intestine. As the inflammation persists, it can lead to scarring, narrowing of the intestines, and complications beyond the digestive tract, such as malnutrition and even other autoimmune disorders (Baumgart & Sandborn, 2012) .
Why Am I Unable to Recover from Crohn
What Are the Causes of Crohn’s Disease?
The exact cause of Crohn’s Disease remains unknown. However, it is believed to result from a combination of genetic predisposition, an overactive immune response, and environmental factors (Ananthakrishnan, 2015) . The immune system mistakenly attacks healthy cells in the GI tract, leading to chronic inflammation. Genetics may also play a role, as Crohn’s tends to run in families. Hormonal and environmental factors, such as diet and stress, can also influence flare-ups and disease progression (Danese & Fiocchi, 2011) .
Crohn’s Disease is not caused by poor hygiene, and it is not contagious.
What Factors Contribute to the Failure of Allopathic/Conventional Treatments?
There are several reasons why conventional Crohn’s Disease medications may stop working or become less effective at managing symptoms over time:
Drug Intolerance: Continuous use of medications, particularly anti-inflammatory drugs or immunosuppressants, can lead to tolerance. Over time, your body may build resistance to certain treatments, making them less effective (Lichtenstein et al., 2012) .
Toxicology: Prolonged use of systemic medications like corticosteroids and immunosuppressants can lead to toxic buildup in vital organs, affecting the liver and kidneys. Long-term use has been linked to serious side effects, including osteoporosis and an increased risk of infection (Torres et al., 2019) .
Anti-drug Antibodies (ADAs): The body can develop antibodies to biologic therapies, reducing their effectiveness over time (Ben-Horin & Chowers, 2011) .
Biologic Depletion: Biologic drugs may lose their potency over time, a phenomenon referred to as biologic fatigue (Ben-Horin & Chowers, 2011) .
Infections: Patients with Crohn’s Disease are more susceptible to infections due to compromised immune systems. Crohn’s medications can exacerbate infections (Torres et al., 2019) .
Misdiagnosis: Crohn’s can sometimes be confused with conditions like IBS or ulcerative colitis. It’s important to confirm the diagnosis with your doctor (Danese & Fiocchi, 2011) .
Stress: Stress can exacerbate Crohn’s Disease. Managing stress through mindfulness and yoga can help reduce the frequency and severity of flare-ups (Ananthakrishnan, 2015) .
Combinations: Improperly combining treatments can lead to drug interactions and long-term side effects (Lichtenstein et al., 2012) .
Time for Treatment to Work: Some medications, like biologics, take weeks or even months to show noticeable results (Baumgart & Sandborn, 2012) . If progress isn’t observed, alternative treatments like Ayurveda can be explored.
When Should You Consider Changing Treatments?
Several signs indicate that it might be time to rethink your Crohn’s Disease treatment:
Ineffectiveness of Treatment: If you don’t see improvement after giving your treatment enough time to work, consider trying alternative approaches (Lichtenstein et al., 2012) .
Worsening Condition: If your symptoms worsen, it may be time to explore new treatments (Baumgart & Sandborn, 2012) .
Toxicity or Side Effects: Conventional drugs have side effects that may necessitate changing treatments (Torres et al., 2019) .
Comorbidities: Development of new conditions like cardiovascular disease may require treatment adjustments (Danese & Fiocchi, 2011) .
Pregnancy or Breastfeeding: Certain medications should be reconsidered during pregnancy (Katz, 2015) .
Unmet Treatment Goals: If your treatment doesn’t meet your goals for quality of life, explore alternatives like Ayurveda.
Ayurvedic Treatment for Crohn’s Disease
At EliteAyurveda, we believe in treating the root causes of Crohn’s Disease rather than just managing symptoms. Our Ayurvedic approach views Crohn’s as a result of imbalances in the Vata and Pitta doshas. We focus on restoring digestive health, reducing inflammation, and promoting long-term wellness through personalized herbal formulations, dietary changes, and lifestyle modifications (Patwardhan, 2013) .
Our Ayurvedic treatments include:
Panchakarma for detoxification.
Herbal formulations to reduce inflammation and balance doshas (Patwardhan, 2013) .
Dietary recommendations tailored to each individual (Patwardhan, 2013) .
Conclusion
Crohn’s Disease can be difficult to manage, but finding the right treatment can dramatically improve your quality of life. If you’re experiencing issues with your current treatment, consider Ayurvedic care to address the root cause of the disease and promote lasting remission. At EliteAyurveda, we are dedicated to helping patients achieve long-term wellness and reduce dependence on conventional medications.
Medically reviewed by Dr. Adil Moulanchikkal, Lead Ayurveda Specialist at EliteAyurveda Clinic.
References
Torres, J., et al. (2019). “Review article: Predictors and Early Markers of Response to Biological Therapies in Inflammatory Bowel Diseases” Alimentary Pharmacology & Therapeutics, 50(6), 559-578. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922976/
Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev. 2004;3:394–400. [PubMed] [Google Scholar]
Loftus EV., Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517. [PubMed] [Google Scholar]
Halfvarson J, Jess T, Magnuson A, et al. Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population [see comment] Inflamm Bowel Dis. 2006;12:925–933. [PubMed] [Google Scholar]
